stockmarketnews.online EDGAR snapshot
The Filings Docket Corporate filings, explained: what large U.S. companies filed with the SEC, and what it means.

In re: ABBOTT LABORATORIES · CIK 0000001800

When will Abbott Laboratories file its next 10-Q?

ABT · NYSE
Snapshot

Abbott Laboratories is expected to file its next quarterly report (Form 10-Q), for the period ending about Sept. 30, 2026, between Oct. 28, 2026 and Nov. 2, 2026, based on its last 8 10-Q filings. The SEC deadline for a large accelerated filer is Nov. 9, 2026.

How the next-report window is calculated

Abbott Laboratories's most recent periodic report on file is a Form 10-Q for the period ended June 30, 2026, filed July 28, 2026. Its fiscal year ends around Dec. 31, so the next period should close about Sept. 30, 2026, and that report is a Form 10-Q.

SEC rules give a large accelerated filer 40 days after period end to file a 10-Q, which lands on Nov. 9, 2026 after moving off weekends and federal holidays. Over its last 8 10-Qs, Abbott Laboratories filed between 28 and 32 days after period end (median 30 days), which gives the expected window above. Period ends are estimated from the company's own calendar and may shift by a few days in 52/53-week fiscal years.

Abbott Laboratories: days from period end to 10-Q/10-K filing 10-Q for period ended 2024-09-30: filed 31 days later; 10-K for period ended 2024-12-31: filed 52 days later; 10-Q for period ended 2025-03-31: filed 30 days later; 10-Q for period ended 2025-06-30: filed 30 days later; 10-Q for period ended 2025-09-30: filed 29 days later; 10-K for period ended 2025-12-31: filed 51 days later; 10-Q for period ended 2026-03-31: filed 29 days later; 10-Q for period ended 2026-06-30: filed 28 days later. 10-Q due: 40d 10-K due: 60d 10-Q · Sept. 30 24 31d 10-K · Dec. 31 24 52d 10-Q · March 31 25 30d 10-Q · June 30 25 30d 10-Q · Sept. 30 25 29d 10-K · Dec. 31 25 51d 10-Q · March 31 26 29d 10-Q · June 30 26 28d days from period end to filing date →

Recent filings by Abbott Laboratories

Most recent 25 filings excluding insider Forms 3/4/5/144 · SEC EDGAR, retrieved Oct. 16, 2026
FiledFormWhat it isDocument
8-K Information shared under Regulation FD; other events the company chose to report Open 8-K filed 2026-08-20 · Index 0001104659-26-099247
10-Q Quarterly report with unaudited financial statements for the period ended June 30, 2026 Open 10-Q filed 2026-07-28 · Index 0001628280-26-050134
8-K Released earnings or financial results Open 8-K filed 2026-07-16 · Index 0001628280-26-048377
11-K Annual report of an employee stock purchase or savings plan Open 11-K filed 2026-06-18 · Index 0001104659-26-075724
SD Specialized disclosure (conflict minerals / resource payments) Open SD filed 2026-05-27 · Index 0001104659-26-066986
13G Ownership above 5% by a passive or institutional investor Open SCHEDULE 13G filed 2026-04-29 · Index 0002100119-26-000151
10-Q Quarterly report with unaudited financial statements for the period ended March 31, 2026 Open 10-Q filed 2026-04-29 · Index 0001628280-26-028357
8-K Executive or board change, or executive pay arrangement; changed its charter, bylaws or fiscal year; reported shareholder vote results Open 8-K filed 2026-04-27 · Index 0001104659-26-049434
S-8 Registration of shares for employee benefit plans Open S-8 filed 2026-04-24 · Index 0001104659-26-048560
8-K Other events the company chose to report Open 8-K filed 2026-04-17 · Index 0001104659-26-044892
8-K Released earnings or financial results Open 8-K filed 2026-04-16 · Index 0001628280-26-025365
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-03-26 · Index 0000102909-26-000500
S-8 Registration of shares for employee benefit plans Open S-8 filed 2026-03-23 · Index 0001104659-26-033413
8-K Other events the company chose to report Open 8-K filed 2026-03-23 · Index 0001104659-26-033079
ARS Annual report delivered to shareholders Open ARS filed 2026-03-13 · Index 0001308179-26-000066
DEFA14A Additional proxy soliciting materials Open DEFA14A filed 2026-03-13 · Index 0001308179-26-000065
DEF 14A Definitive proxy statement for a shareholder meeting Open DEF 14A filed 2026-03-13 · Index 0001308179-26-000064
8-K Signed a material contract; took on new debt or a similar obligation Open 8-K filed 2026-03-09 · Index 0001104659-26-025240
8-K Signed a material contract Open 8-K filed 2026-02-26 · Index 0001104659-26-020509
S-3ASR Automatic shelf registration (well-known seasoned issuer) Open S-3ASR filed 2026-02-23 · Index 0001104659-26-018381
8-K Changed its charter, bylaws or fiscal year Open 8-K filed 2026-02-20 · Index 0001104659-26-018167
10-K Annual report with audited financial statements for the period ended Dec. 31, 2025 Open 10-K filed 2026-02-20 · Index 0001628280-26-010185
8-K Released earnings or financial results Open 8-K filed 2026-01-22 · Index 0001628280-26-002982
8-K Executive or board change, or executive pay arrangement; changed its charter, bylaws or fiscal year Open 8-K filed 2025-12-12 · Index 0001104659-25-120657
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2025-12-03 · Index 0000102909-25-000355

What Abbott Laboratories's 8-Ks were about in the past year

Abbott Laboratories filed 13 Form 8-K current reports between Oct. 17, 2025 and Oct. 16, 2026. Each report lists the item numbers it covers; the counts below show how often each item appeared.

ItemMeaningTimes
9.01Financial Statements and Exhibits13
8.01Other Events4
2.02Results of Operations and Financial Condition3
5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year3
1.01Entry into a Material Definitive Agreement3
7.01Regulation FD Disclosure2
5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers2
5.07Submission of Matters to a Vote of Security Holders1
2.03Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement1
5.04Temporary Suspension of Trading Under Registrant's Employee Benefit Plans1

See what each 8-K item means.